Literature DB >> 12604916

Impaired insulin action on phosphatidylinositol 3-kinase activity and glucose transport in skeletal muscle of pancreatic cancer patients.

Bengt Isaksson1, Lisa Strömmer, Helmut Friess, Markus W Büchler, Margery K Herrington, Feng Wang, Juleen R Zierath, Harriet Wallberg-Henriksson, Jörgen Larsson, Johan Permert.   

Abstract

INTRODUCTION: Glucose intolerance or overt diabetes occurs in 80% of patients with pancreatic cancer (PC). This associated metabolic disorder includes peripheral insulin resistance, which may be caused by factors produced by the PC. The mechanism underlying PC-associated insulin resistance has not been clearly defined. AIM: To characterize basal and insulin-stimulated glucose transport, phosphatidylinositol (PI) 3-kinase activity, and glucose transporter 4 (GLUT4) in skeletal muscles of PC patients.
METHODOLOGY: Skeletal muscle samples were obtained from the abdominal wall of 17 PC patients during surgery. Control muscles were sampled in the same way from 11 donors undergoing abdominal surgery for benign diseases. PI 3-kinase activity, glucose transport, and GLUT4 were assessed in vitro in these muscles.
RESULTS: In the presence of physiologic concentrations of insulin, glucose transport and PI 3-kinase activity were significantly decreased in the PC group compared with controls. At supraphysiologic insulin concentrations, glucose transport was significantly decreased but PI 3-kinase activity was normalized. In the absence of insulin, these parameters were not significantly different between PC and control groups. Muscle GLUT4 contents were similar between PC and control groups.
CONCLUSION: Defects in insulin-mediated PI 3-kinase activity and glucose transport contribute to the insulin resistance in patients with PC.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12604916     DOI: 10.1097/00006676-200303000-00014

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  12 in total

Review 1.  New insights into pancreatic cancer-induced paraneoplastic diabetes.

Authors:  Raghuwansh P Sah; Sajan Jiv Singh Nagpal; Debabrata Mukhopadhyay; Suresh T Chari
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-26       Impact factor: 46.802

Review 2.  Diabetes mellitus: a risk factor for pancreatic cancer?

Authors:  M Yalniz; P M Pour
Journal:  Langenbecks Arch Surg       Date:  2004-04-09       Impact factor: 3.445

3.  Aberrant p38 mitogen-activated protein kinase signalling in skeletal muscle from Type 2 diabetic patients.

Authors:  H A Koistinen; A V Chibalin; J R Zierath
Journal:  Diabetologia       Date:  2003-08-23       Impact factor: 10.122

4.  Adrenomedullin is up-regulated in patients with pancreatic cancer and causes insulin resistance in β cells and mice.

Authors:  Gaurav Aggarwal; Vijaya Ramachandran; Naureen Javeed; Thiruvengadam Arumugam; Shamit Dutta; George G Klee; Eric W Klee; Thomas C Smyrk; William Bamlet; Jing Jing Han; Natalia B Rumie Vittar; Mariza de Andrade; Debabrata Mukhopadhyay; Gloria M Petersen; Martin E Fernandez-Zapico; Craig D Logsdon; Suresh T Chari
Journal:  Gastroenterology       Date:  2012-09-06       Impact factor: 22.682

Review 5.  Diabetes and pancreatic cancer.

Authors:  T Muniraj; S T Chari
Journal:  Minerva Gastroenterol Dietol       Date:  2012-12

6.  Prevalence of diabetes mellitus in pancreatic cancer compared to common cancers.

Authors:  Gaurav Aggarwal; Pratima Kamada; Suresh T Chari
Journal:  Pancreas       Date:  2013-03       Impact factor: 3.327

7.  Insulin signalling and resistance in patients with chronic heart failure.

Authors:  Jukka Kemppainen; Hiroki Tsuchida; Kira Stolen; Håkan Karlsson; Marie Björnholm; Olli J Heinonen; Pirjo Nuutila; Anna Krook; Juhani Knuuti; Juleen R Zierath
Journal:  J Physiol       Date:  2003-05-09       Impact factor: 5.182

Review 8.  New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer.

Authors:  Rahul Pannala; Ananda Basu; Gloria M Petersen; Suresh T Chari
Journal:  Lancet Oncol       Date:  2009-01       Impact factor: 41.316

9.  Activity of the Akt-dependent anabolic and catabolic pathways in muscle and liver samples in cancer-related cachexia.

Authors:  Thomas L Schmitt; Marcus E Martignoni; Jeannine Bachmann; Kerstin Fechtner; Helmut Friess; Ralf Kinscherf; Wulf Hildebrandt
Journal:  J Mol Med (Berl)       Date:  2007-03-02       Impact factor: 5.606

Review 10.  The relationship between diabetes and pancreatic cancer.

Authors:  Feng Wang; Margery Herrington; Jörgen Larsson; Johan Permert
Journal:  Mol Cancer       Date:  2003-01-06       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.